Patient-first surveillance

Bladder Cancer
Surveillance Anywhere

HomeScope brings bladder surveillance closer to patients with guided capture, secure delivery, and clinician review designed around real-life schedules.

Study Pack

Structured stills + clips

Onboard processing

Transfer

Secure upload

Clinician handoff

Patient-ready workflow

Home kit delivery, guided capture, and secure handoff keep care moving without unnecessary travel.

  • Clear steps for each session
  • Secure transfer to urologists
  • Support for asynchronous review

Guided Capture

Step-by-step guidance supports consistent imaging for every session.

Multi-Camera Array

Multi-camera optics help capture key bladder views in a single session.

🗂

Secure Delivery

Encrypted payloads are transmitted to the care team for review.

83,000
Annual Bladder Cancer Cases
63%
Counties Without Urologists
78%
5-Year Bladder Cancer Survival Rate
6th
Most common cancer in the U.S.

Guided Capture

Step-by-step guidance supports consistent imaging for every session.

Multi-Camera Array

Multi-camera optics help capture key bladder views in a single session.

🗂

Secure Delivery

Encrypted payloads are transmitted to the care team for review.

Introducing the HomeScope 18Fr Catheter

HomeScope is a compact, flexible cystoscopic imaging device engineered to enable standardized bladder visualization outside of traditional urology clinics. The device integrates a miniaturized optical imaging system within a soft, atraumatic catheter designed to follow established catheterization workflows.

The distal imaging module incorporates high-resolution camera sensors and controlled illumination optimized for urothelial visualization. During insertion and withdrawal, the system captures sequential images using automated or guided motion control. These images are algorithmically stitched into a panoramic representation of the bladder.

Image capture parameters—including exposure, focus, and field-of-view overlap—are controlled by the system to support consistent acquisition across users and environments. Captured images are securely transmitted to a cloud-based platform for asynchronous review by a urologist.

The device architecture is designed for single-use deployment. HomeScope is being developed to comply with Class II medical device standards, with ongoing preclinical validation focused on image quality, usability, and safety in bladder models prior to clinical feasibility studies.

Precision navigation Remote collaboration Guided workflows SBIR-ready Industry-standard imaging

Clinical Network

Backed by Texas A&M Engineering Medicine

HomeScope was incubated within Texas A&M University’s ENMED program alongside Houston Methodist, ensuring every iteration is reviewed by clinicians who understand the reality of cystoscopy outside traditional facilities.

Joint development between Houston-based clinicians and ENMED engineers keeps the device grounded in day-to-day workflows.

ENMED, Texas A&M University, and Houston Methodist logos together

Why it matters

The Problem We're Solving

Bladder cancer has one of the highest recurrence rates of any cancer, requiring frequent monitoring. Current cystoscopy methods are costly, inconvenient, and often delayed.

Limited Access to Care

63% of US counties lack a urologist. Rural patients travel 34 miles on average to the nearest specialist.

High Societal Cost

Bladder cancer is one of the most expensive diagnoses to treat due to repeat procedures and lost time from work.

High Recurrence Rates

Non-muscle invasive cases require relentless surveillance cystoscopies with little relief for patients.

Lack of Follow-Up

Scheduling constraints and access barriers lead to missed appointments, increasing progression risk.

Geographic Disparity in Urologic Care

Map of U.S. counties showing total number of practicing urologists by density

Source: American Urological Association Journals (2020)

63%

of US counties lack a urologist

34 vs 10

miles rural vs. urban patients travel for urologists

9%

of urologists serve 20% of US rural populations

Solution

A Medical Device Built for Anywhere

A novel at-home cystoscopy device that combines medical-grade design with patient-friendly workflows, making regular bladder monitoring accessible without compromising clinician review.

The Technology

An 18Fr catheter with multi-camera optics, onboard capture, and post-processing that compiles stills and video for urologists. Biocompatible materials, sterile packaging, and reliable lighting support repeatable procedures anywhere.

Holographic Device Mock

Clinical Oversight

Off-site urologists receive structured capture sets linked to each visit.

Review-ready Clinician packets

Imaging

Industry-standard image capture

HomeScope supports industry-standard image capture with guided workflows and HD accuracy for consistent review across sessions.

Industry-standard image capture

Industry-Standard Imaging

Multi-camera views designed for clear, consistent review by urologists.

Self-Operation Capable

Designed to allow self-catheterization by patients or use by primary care providers.

Reduces Clinical Burden

Shifts examinations from clinics to homes while retaining procedural quality.

Improves Compliance

Increases adherence to surveillance guidelines through convenience and comfort.

Expands Access

Mail-in kits serve patients in rural areas and those far from urologists.

Secure Transmission

Uploads encrypted stills and clips to urologists for remote review.

Team

Meet Our Team

A multidisciplinary team of physicians, engineers, and innovators transforming urologic care.

Aaryan Jadhav headshot

Aaryan Jadhav

MD & M.Eng Candidate

Former Management Consultant Serving Fortune 500 Pharma Innovation Units.

Dr. Emily Huang headshot

Dr. Emily Huang

Urologic Oncology Fellow

Urologic Oncology Fellow at Mass General Brigham & Blavatnik Innovation Fellow at the Harvard HealthTech Program. Urology Residency at Houston Methodist Hospital | MD at UT Southwestern | BA at Rice University.

Brandon Look Fong headshot

Brandon Look Fong

MD & M.Eng Candidate

Former Lead Investigator for a Vascular Surgery Engineering Lab.

Rijul Nanda headshot

Rijul Nanda

MD & M.Eng Candidate

Former Product/Test Engineer at Texas Instruments Specializing in Imaging Sensors.

Dr. Ricardo Gonzalez headshot

Dr. Ricardo Gonzalez

Urologist, Houston Methodist

Principal Clinical Partner Guiding Procedure Workflow and Adoption.

Varun Kumar headshot

Varun Kumar

MD & M.Eng Candidate

Former LVAD Engineer at Emory Healthcare Delivering Rigorous Device Validation.

Sabour Shaik headshot

Sabour Shaik

MD & M.Eng Candidate

Former Bladder Cancer Clinical Research Coordinator and Radical Cystectomy Navigator.

Recognition

Awards & Recognition

Celebrated by healthcare organizations and innovation showcases.

Phase 1

AUA Innovation Nexus

Selected poster + live demo, April 2025.

Clinical

Houston Methodist MedTech Summit

Top concept for distributed cystoscopy.

Funding

SBIR Pipeline

Preparing Phase I submission with partner sites.

Evidence

Research & Publications

Benchtop validation and verification are ongoing, with IRB drafting underway for clinical evaluation.

Conference

Rice360 Innovation for Healthcare Access Conference

Houston, TX (Oct 2025) · Innovation Marketplace presentation

Expo

Tufts Innovation Expo

Boston, MA (Oct 2025) · Poster presentation

Conference

Collaborative Advancements in Research & Education (CARE) Conference

Dallas, TX (Oct 2025) · Poster presentation

AUA

American Urological Association Innovation Nexus Boot Camp

Baltimore, MD (Sept 2025) · Showcase presentation

AUA

American Urological Association Innovation Nexus Showcase

Las Vegas, NV (Apr 2025) · Showcase presentation

Conference

Houston Global Health Conference

Houston, TX (Apr 2025) · Poster presentation

Symposium

EnMed 2nd Annual Emerging Health Innovation Symposium

Houston, TX (Apr 2025) · Poster presentation

Symposium

Houston Methodist Neurogenic Bladder Research Symposium

Houston, TX (2024) · Symposium presentation

Roadmap

Where We're Headed

A phased plan to deploy HomeScope into patient homes.

Phase 1

Biodesign Sprint

Completed initial needs assessment and feasibility (Nov 2024).

● Completed

Phase 2

Product Development

Camera technology development and preliminary testing (Early 2025).

● Completed

Phase 3

AUA Innovation Nexus

Clinical validation, regulatory strategy, and pilot studies.

● In Progress

Phase 4

Capstone & SBIR Funding

Phase 1 SBIR submission and capstone completion (2025-2026).

● In Planning

Phase 5

Pre-Clinical Testing

3D printed models + animal studies in preparation for clinical trials.

● Next

✉️

Get in Touch

Interested in collaborating, piloting, or learning more about HomeScope? We'd love to hear from you.